The FDA announced on April 10, 2020, that Medtronic Inc. is recalling its Implantable Insulin Pump System due to potential endotoxin contamination. This hazard could cause fever, shock, or death in patients. The recall affects pumps distributed outside the U.S.
How to tell if you have it
- Brand: Medtronic
- Product: Medtronic Implantable Insulin Pump System
- REF: MMT-2007D
- UDI: 00763000043001
- Lots produced May 21, 2019 to present
- Serial numbers: 31359, 31360, and 31332
- Quantity: 24 pumps
The hazard
Internal testing showed the device did not meet specifications for endotoxin levels. If pumps have higher than allowed endotoxin levels, patients may experience fever, hypotension, anaphylactic shock, hyperglycemia, or diabetic ketoacidosis (DKA). These conditions can potentially lead to secondary multi-organ failure and/or death.
Context
GovInfoNow's records show Medtronic has 38 other recalls on record since September 10, 2017. Recent similar insulin pump recalls include the MiniMed 780G (July 13, 2026) and the MiniMed 670G (July 13, 2026), both citing risks of incorrect insulin delivery. Other recent Medtronic device recalls involve the Sphere-9 Catheter (March 11, 2026) and the Abre Venous Stent (December 4, 2025).